FDA Compliant Handling of Out-of-Trend Results in Pharmaceutical Quality Control
This webinar will discuss the FDA requirements and guidelines for investigating Out-of-trend (OOT) results in the pharmaceutical laboratory. It will also cover FDA-compliant documentation of OOT, failure investigations, root causes, and CAPA.
- FDA regulations and guidelines.
- FDA's final Guidance for Industry: Investigating Out-of-Specification (OOS) Test Results for Pharmaceutical Production.
- Difference between OOS and OOT results.
- Developing SOPs for OOT situations and laboratory failures.
- Investigating OOT results: what and how.
- Retesting of OOT results.
- Using historical data for OOT evaluation.
- Using QC samples and product control charts for evaluation.
- Developing corrective and preventive action plans.
- Finding the root cause for OOT results.
- Strategies to avoid OOS situations BEFORE they occur.
- FDA-compliant documentation of OOS, OOT, failure investigations, root causes, and CAPA.
FDA's guidance on OOS test results requires failure investigations and other steps for Out-of-Specification (OOS) and Out-of-trend (OOT) results. While most companies are familiar with and have procedures for OOS results, this is not the case for OOT situations. The guide states: "Although the subject of this document is OOS results, much of the guidance may be useful for examining results that are out of trend". Managing OOT results also helps to avoid time-consuming OOS results. The industry is unsure how to interpret and implement the FDA guidance.
This session will equip you with the knowledge and comprehensive understanding of FDA requirements for Out-of-Trend Results in pharmaceutical quality control.
- Lab Supervisors and Managers
- QA managers and personnel
- Pharmaceutical R&D personnel
- Documentation
- Consultants
- Contract laboratories
- CROs
Ms. Thomas has over two decades of cGMP hands-on industry experience in both pharmaceutical and medical device manufacturing operations. Her experience covers all Quality Systems; as well as, all areas of validation; including, process/product validation, facilities validation, CSV and 21 CFR Part 11, test method validation, equipment/automated processes and cleaning validation.
Utilizing strategic thinking, risk based approaches, and Lean principles, she has demonstrated success in steering and managing complex projects within the pharmaceutical and medical device industries.
Upcoming Webinars
By Edwin Waldbusser
Date: Nov. 1, 2024
By Ginette M. Collazo
Date: Nov. 4, 2024
By Diane L. Dee
Date: Nov. 4, 2024
By Dr. Susan Strauss
Date: Nov. 4, 2024
By Meredith Crabtree
Date: Nov. 4, 2024
By Marcia Zidle
Date: Nov. 6, 2024
By William Mack Copeland
Date: Nov. 6, 2024
By Bob McKenzie
Date: Nov. 6, 2024
By David Nettleton
Date: Nov. 7, 2024
By Marcia Zidle
Date: Nov. 7, 2024
By Richard E Cascarino
Date: Nov. 8, 2024
By Jose Ignacio Mora
Date: Nov. 8, 2024
By Meena Chettiar
Date: Nov. 8, 2024
By Bruce Lee
Date: Nov. 8, 2024
By Gary Heppner
Date: Nov. 13, 2024
By Joseph Wolfe
Date: Nov. 14, 2024
By Justin Muscolino
Date: Nov. 14, 2024
By Melveen Stevenson
Date: Nov. 14, 2024
By Justin Muscolino
Date: Nov. 15, 2024
By Michael Healey
Date: Nov. 15, 2024
By Mark Gorkin
Date: Nov. 18, 2024
By Cathy Horwitz
Date: Nov. 18, 2024
By Jonnie Keith
Date: Nov. 18, 2024
By Marcia Zidle
Date: Nov. 19, 2024
By Bob McKenzie
Date: Nov. 19, 2024
By Bob McKenzie
Date: Nov. 19, 2024
By David Nettleton
Date: Nov. 20, 2024
By Bruce Lee
Date: Nov. 21, 2024
By Dr. Susan Strauss
Date: Nov. 25, 2024
By Cathy Horwitz
Date: Dec. 20, 2024
By Margie Faulk
Recorded Session
By Miles Hutchinson
Recorded Session
By Deborah Covin Wilson
Recorded Session
By Donna K Olheiser
Recorded Session
By Catherine M. Mattice
Recorded Session
By Neil Malek
Recorded Session
By Deborah Covin Wilson
Recorded Session
By Ray Graber
Recorded Session
By Janette Levey Frisch
Recorded Session
By Paul J. Sanchez
Recorded Session
By Catherine M. Mattice
Recorded Session
By Danielle DeLucy
Recorded Session
By Lisa Marsden
Recorded Session
By E. Pete Lewis
Recorded Session
By Mike Thomas
Recorded Session
By Deborah Covin Wilson
Recorded Session
By Jeff Kasoff
Recorded Session
By Candace Curry Leuck
Recorded Session
By Loren Gelber
Recorded Session
By Rebecca Staton-Reinstein
Recorded Session
By Marcia Zidle
Recorded Session
By Paul R Hales
Recorded Session
By Paul J. Sanchez
Recorded Session
By Margie Faulk
Recorded Session
By Deborah Covin Wilson
Recorded Session
By Lisa Marsden
Recorded Session
By Michael D Haberman
Recorded Session
By Mike Thomas
Recorded Session
